A comprehensive transcriptional portrait of human cancer cell lines
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive transcriptional portrait of human cancer cell lines
Authors
Keywords
-
Journal
NATURE BIOTECHNOLOGY
Volume 33, Issue 3, Pages 306-312
Publisher
Springer Nature
Online
2014-12-09
DOI
10.1038/nbt.3080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data
- (2013) Nameeta Shah et al. BMC GENOMICS
- The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology
- (2013) O. D. Abaan et al. CANCER RESEARCH
- Lessons from the Cancer Genome
- (2013) Levi A. Garraway et al. CELL
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Inconsistency in large pharmacogenomic studies
- (2013) Benjamin Haibe-Kains et al. NATURE
- Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2
- (2013) M. Acunzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brief Report: The lincRNA Hotair Is Required for Epithelial-to-Mesenchymal Transition and Stemness Maintenance of Cancer Cell Lines
- (2013) Cleidson Pádua Alves et al. STEM CELLS
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers
- (2013) Yi-Mi Wu et al. Cancer Discovery
- Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events
- (2012) J. Liu et al. GENOME RESEARCH
- The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients
- (2012) Z. Jiang et al. GENOME RESEARCH
- Detection of Murine Leukemia Virus in the Epstein-Barr Virus-Positive Human B-Cell Line JY, Using a Computational RNA-Seq-Based Exogenous Agent Detection Pipeline, PARSES
- (2012) Z. Lin et al. JOURNAL OF VIROLOGY
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Recurrent R-spondin fusions in colon cancer
- (2012) Somasekar Seshagiri et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants
- (2012) Wenqing Fu et al. NATURE
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
- Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, Condel
- (2011) Abel González-Pérez et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition
- (2011) K. P. Hoeflich et al. CANCER RESEARCH
- Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
- (2011) Daniel P. Sutherlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
- (2011) Dan R Robinson et al. NATURE MEDICINE
- deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
- (2011) Andrew McPherson et al. PLoS Computational Biology
- Identification of fusion genes in breast cancer by paired-end RNA-sequencing
- (2011) Henrik Edgren et al. GENOME BIOLOGY
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Fast and SNP-tolerant detection of complex variants and splicing in short reads
- (2010) T. D. Wu et al. BIOINFORMATICS
- Integrative analysis of the melanoma transcriptome
- (2010) M. F. Berger et al. GENOME RESEARCH
- Signatures of mutation and selection in the cancer genome
- (2010) Graham R. Bignell et al. NATURE
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- A global map of human gene expression
- (2010) Margus Lukk et al. NATURE BIOTECHNOLOGY
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- (2010) J. H. Taube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data
- (2009) C. D. Greenman et al. BIOSTATISTICS
- Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
- (2009) R. Drmanac et al. SCIENCE
- Crosstalk in Met receptor oncogenesis
- (2009) Andrea Z. Lai et al. TRENDS IN CELL BIOLOGY
- The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
- (2008) Stephen D. Barrett et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors
- (2008) U. McDermott et al. CANCER RESEARCH
- The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†
- (2008) Adrian J. Folkes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing
- (2008) Peter J Campbell et al. NATURE GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started